SCHEMBL10463573

SCHEMBL10463573

NC(=O)/C=C/[C@H]1[C@H](N)C(=O)N1S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10464572 0.75
SCHEMBL10464173 0.75
SCHEMBL10992633 0.72 KDM1A (0.39)
SCHEMBL10657542 0.72 KDM1A (0.39)
SCHEMBL10657548 0.72 KDM1A (0.39)
SCHEMBL10657533 0.72 KDM1A (0.39)
SCHEMBL10463621 0.69
SCHEMBL15142621 0.69
SCHEMBL10463710 0.69
SCHEMBL10736523 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4948898-A MICROBIOCIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 1990-08-14 US disclosed
US-4652651-A Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage HOFFMANN-LA ROCHE INC. (US) 1987-03-24 US disclosed
EP-0096297-A2 Process for the preparation of 1-sulfo-2-oxoazetidine derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-12-21 EP disclosed